BRIEF—Isoprotrace launched in Germany

Israel-based radiopharma company Isotopia has launched Isoprotrace in Germany, supported by distribution partner DSD Pharma.

Isoprotrace is a radiopharmaceutical product used for prostate cancer imaging. The multi-dose kit allows for the rapid and efficient preparation of Gallium (68Ga) Gozetotide solution for intravenous injection. 

After radiolabelling with gallium (68Ga) chloride solution, Isoprotrace is indicated for positron emission tomography of prostate-specific membrane antigen-positive lesions in men with prostate cancer in certain clinical settings.